AgeX Therapeutics, Inc. (AGE)

SG&A Expense Growth

-3.67%

Quarterly · Period ending:

AGE logo

AGE SG&A Expense Growth

Latest reported-3.67%
AGE Quarterly SG&A Growth (QoQ) (0.00% → -3.67%)
High-resolution chart · PNG

AGE sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-3.6676%
9.8004%
2.3714%
7.7861%
-12.5215%
3.8585%
-3.8475%
25.3121%
90.4098%
-64.4626%
58.0571%
25.5491%
-13.1962%
26.0595%
13.5776%
4.0359%
-19.3976%
9.4265%
6.7558%
-18.7071%
-13.5509%
17.0139%
-11.3391%
17.9068%
-20.2605%
20.7338%
-21.7411%
3.5394%
0.4742%
7.1646%
56.9378%
10.4846%
-12.0155%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.